chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report was received from a pharmacist referring to a patient of unknown age and gender. No information about the patient's medical history, concurrent conditions, drug reactions or allergies and concomitant therapies was provided. On 03-FEB-2017 at 15:45, the patient was vaccinated with an improperly stored VARIVAX (lot # M031969) for prophylaxis (expiration date, dose and route of administration were not reported). It was reported that the vaccine underwent previous temperature excursions, but the number of previous excursions, time frames and values of incorrect temperature were unknown. A digital data logger was used. No adverse effects were reported. Product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested.; Sender's Comments: US-009507513-1701USA008441: US-009507513-1704USA000389: US-009507513-1704USA000390: US-009507513-1704USA000391: US-009507513-1704USA000392: US-009507513-1704USA000393: US-009507513-1704USA000394: US-009507513-1704USA000395: US-009507513-1704USA000396: US-009507513-1704USA000397: US-009507513-1704USA000398: US-009507513-1704USA000399: US-009507513-1704USA000400: US-009507513-1704USA000401: US-009507513-1704USA000402: US-009507513-1704USA000403: US-009507513-1704USA000404: US-009507513-1704USA000405: US-009507513-1704USA000406: US-009507513-1704USA000407: US-009507513-1704USA000408: US-009507513-1704USA000409: US-009507513-1704USA000410: US-009507513-1704USA000411: US-009507513-1704USA000412: US-009507513-1704USA000413: US-009507513-1704USA000414: US-009507513-1704USA000415: US-009507513-1704USA000416: US-009507513-1704USA000417: US-009507513-1704USA000418: US-009507513-1704USA000419: US-009507513-1704USA000420: US-009507513-1704USA000421: US-009507513-1704USA000422: US-009507513-1704USA000423: US-009507513-1704USA000424: US-009507513-1704USA000425: US-009507513-1704USA000426: US-009507513-1704USA000427: US-009507513-1704USA000428: US-009507513-1704USA000429: US-009507513-1704USA000430: US-009507513-1704USA000431: US-009507513-1704USA000432: US-009507513-1704USA000433: US-009507513-1704USA000434: US-009507513-1704USA000435: US-009507513-1704USA000436: US-009507513-1704USA000438: US-009507513-1704USA000439: US-009507513-1704USA000440: US-009507513-1704USA000441: US-009507513-1704USA000442: US-009507513-1704USA000443: US-009507513-1704USA000444: US-009507513-1704USA000445: US-009507513-1704USA000446: US-009507513-1704USA000447: US-009507513-1704USA000448: US-009507513-1704USA000449: US-009507513-1704USA000450: US-009507513-1704USA000451: US-009507513-1704USA000452: US-009507513-1704USA000453: US-009507513-1704USA000454: US-009507513-1704USA000455: US-009507513-1704USA000456: US-009507513-1704USA000457.
The injection site is red; throbbing on and off and sometimes constantly; headache; This is a spontaneous report from a contactable consumer. This consumer (patient) reported that a 33-years-old female patient received second dose of bnt162b2 (BNT162B2; PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported.  The patient experienced the injection site was red, throbbing on and off and sometimes constantly, headache, all on an unspecified date with outcome of unknown. All events reported as non-serious.   Information about batch/lot number has been requested.
After giving pt meningococcal he developed an immediate localized wheal at place of SQ injection in right arm. Pt lungs clear no wheezing noted. Noted a reduction in wheal in 20 mins. Was observed until 10 am area less than 2".
break out in full body rash, skin fells like it's burning and pins and needles this is the 3rd break out since the vaccination
Morning following vaccination, patient had diffuse rash and nausea. Presented to ED and progressed to lightheadedness, difficulty hearing and hypotension. Patient took diphenhydramine at home prior to presentation to ED. Epinephrine was administered in the ED.
pt had several szs 5 days p/shots; pt was taken to hosp p/extensive testing, (MRI, EEG, spinal tap-etc) pt was sent home on Phenarb; No explanation for cause of sz was given;
Chest pain. Nausea, light headedness, left hip pain, swollen lymph nodes, increase in headaches and migraines  Chest x ray completed negative for myocarditis labs completed stable Given tordal and Zofran barely effective
10-16-08 received FluMist, 11-02-08 developed Pnuemomediastinum & first time wheezing. No prior history of asthma. Admitted to hospital Dx: first time Unspecific Asthma with Status Asthmaticus, Pneumomediastinum with extensive bilateral subcutaneous emphysema.  12/16/2008 MR received for DOS 11/2-3/2008 with D/C DX:  Pneumomediastinum. Unspecified asthma with status asthmaticus. Pt presented with fever, cough, neck swelling and chest pain.  PE (+) for bilateral crepitus of the neck. Started on assthma protocol requiring O2 supplementation.
Within minutes after receiving vaccine experienced flushing of face and upper chest. Complained of feeling funky. Was taken to ER after approximately 15 minutes with improvement. In ER she experienced chest pain, SOB, and nausea. After receiving IV Benadryl and Decadron without complete resolution of symptoms, she was admitted. The discharge summary received on 3/23/04 states restrictive lung disease.
My symptoms started on 1/12/21 and lasted through 1/13/21. My highest temp. was 102.5 F.
Moderna 4/21/21, 5/19/21, 1/19/22, 4/12/22. Positive on 12/27/22
Patient was given Dtap INFANRIX and was supposed to be given Tdap for 7 years and up.
rash; This is a spontaneous report from a contactable consumer, the parent. A 12-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration on 22Jul2021 as dose 2, single (at the age of 12-years-old) for covid-19 immunization. Medical history reported as none. The patient concomitant medications were not reported. The patient previously took bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, solution for injection, lot number: unknown), via an unspecified route of administration in the arm left on 01Jul2021 as dose 1, single (at the age of 12-years-old) for covid-19 immunization and experienced sore arm. On 26Jul2021, the patient experienced rash. The patient took allergy medicine for the treatment of event. The patient had not gone in emergency room and also not visited to physician office. There were not any adverse event present prior to the vaccination. The outcome of the event was recovering.  Follow-up attempts were completed. No further information was expected.
Rhinorrhea/ Runny Nose; Unevaluable event. Information regarding Flumist (2003-2004 Formula) (influenza virus vaccine, live intranasal (2003-2004 formula) nasal solution (forzen)) was received from a father regarding his 9 year old son who developed a runny nose and "felt run down" . The patient received the first dose on an unspecified date. The patient's 7 year old brother experienced a similar reaction (see MCN: HQWYE812104FEB04). No additional information was available at the time of this report.
Patient came in 2 weeks later stating she was in the hospital for an infection and believes it was from the way the vaccine was administered. She was picking up medications from the hospital and said that she was feeling pain in the side of her neck
Couldn't lift arm about the shoulder; Arm felt warm; Thought she would pass out; Dizzy; Couldn't eat anything; Sweating like she was going to pass out; Barfing; Arm hurt a little bit; Headache; This spontaneous case was reported by a consumer and describes the occurrence of LIMB DISCOMFORT (Couldn't lift arm about the shoulder), VACCINATION SITE WARMTH (Arm felt warm), PRESYNCOPE (Thought she would pass out), DIZZINESS (Dizzy) and DECREASED APPETITE (Couldn't eat anything) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included GLIPIZIDE and HYDROCHLOROTHIAZIDE, LOSARTAN POTASSIUM (LOSARTAN/HYDROCHLOROTHIAZIDE) for an unknown indication.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LIMB DISCOMFORT (Couldn't lift arm about the shoulder), VACCINATION SITE WARMTH (Arm felt warm), PRESYNCOPE (Thought she would pass out), DIZZINESS (Dizzy), DECREASED APPETITE (Couldn't eat anything), HYPERHIDROSIS (Sweating like she was going to pass out), VOMITING (Barfing), VACCINATION SITE PAIN (Arm hurt a little bit) and HEADACHE (Headache). At the time of the report, LIMB DISCOMFORT (Couldn't lift arm about the shoulder), VACCINATION SITE WARMTH (Arm felt warm), PRESYNCOPE (Thought she would pass out), DIZZINESS (Dizzy), DECREASED APPETITE (Couldn't eat anything), HYPERHIDROSIS (Sweating like she was going to pass out), VOMITING (Barfing), VACCINATION SITE PAIN (Arm hurt a little bit) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was reported.
The patient was 17 years old when he received the Moderna Covid-19 vaccine.  The registration and nursing staff who were administering the vaccine to essential workers (restaurant worker in this case) failed to check his date of birth carefully on 03/12/21 (the date of vaccine administration).  The Registration Staff discovered this error when checking the appointment list on April 8, 2021. Patient was on the list to get his second dose on April 9th. The patient did not report any adverse events from the 1st dose of the  Moderna  Covid-19 vaccine and wanted to come in and get his second dose when he was contacted on April 8th regarding this error.
Patient reports that on day of vaccination she developed pain in left deltoid (monday) Over the course of the next three days she subsequently developed "lancing pain" radiating to the hand as well as left forearm, wrist, and hand swelling. By thursday 10/7/2021 she had pain with palpation of the hand wrist and fore arm. She notes reduced grip strength and difficulty with performing daily tasks such as dressing due to pain
Long lasting, profound fatigue, "brain fog" that interferes with work duties, mild head ache.  I will call my doctor on Monday if these symptoms persist.  Not sure what can be done about it.  I worry that I am permanently damaged.
onset of redness, itchiness and a bump on her left arm where vaccination was given; size > quarter. She did see her PCP Dr.  Apparent localized reaction. She apparently presented to Dr.(unknown is VAERS filed per their office.  She also states she continues to be fatigued however with further Hx it is apparent fatigue has been an apparent longstanding concern previously worked up by OB/GYN.
This spontaneous report has received from a pharmacist referring to a 63 year old female patient with stomach reflux and latex sensitivity. No information was provided regarding the patient medical history. On 06-SEP-2017, the patient was vaccinated with ZOSTAVAX (strength and dose were not provided) lot # N012492, expiration date 17-MAR-2018, in the right arm for prophylaxis.  Other suspect therapies included sterile diluent (MRK), lot#M013638, expiration date 19-NOV-2018. Concomitant medication included an unspecified medication for stomach reflux (unspecified details). On 07-SEP-2017, the patient experienced a reddened area the size of a baseball at the injection site. No laboratory diagnostics were performed. The outcome of injection site erythema was unknown. The causality between the event and ZOSTAVAX was not reported.
Gums swollen, upper lip tender & puffy & dry, causing me to constantly wet lip w/tongue same condition w/lower lip, very annoying especially at night.
Someone injected Moderna on my left ar on 4/14/2021 and 5/19/2021.  I left arm felt some pain.
No additional AE reported; The MMR-II expired on 6/30/2021 and was inadvertently administered on 7/1/2021; Information has been received from a medical assistant referring to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/ allergies and concomitant medication were not reported.  On 01-JUL-2021, the patient was inadvertently vaccinated with an expired Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) (lot# S020160, expiration date 30-JUN-2021; dose, strength, frequency and route unknown) for prophylaxis (Expired product administered). The Measles, Mumps, and Rubella (Wistar RA 27-3) Virus Vaccine, Live (M-M-R II) had never had any temperature excursions. No additional adverse event (AE) reported.
painic attack; This spontaneous case was reported by a consumer and describes the occurrence of PANIC ATTACK (painic attack) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PANIC ATTACK (painic attack). The patient was treated with ALPRAZOLAM at a dose of UNK dosage form. At the time of the report, PANIC ATTACK (painic attack) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Mar-2021, Heart rate: increased (Inconclusive) Heart beat raising.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       concomitant medications include alprazolam. After 3 hours patient  heart was started raising. She had a panic attack..
Severely bad headache (she has been in tears and didn't want to play video games she felt so bad. She is complaining of feeling like she was going to throw up but that has been for over a month now and has 100% to do with her anxiety. The headache however is related I believe.
mom states  pt recv vax & started screaming & nothing would settle pt;cry unusual squeal, scream high pitched 6-8hr non stop;refused bottle, pacifier was sweaty & exhausted;restless-didn't sleep through noc;next day if touched squealed;
positive COVID-19 test with symptoms; positive COVID-19 test with symptoms; This is a spontaneous report from a contactable other healthcare professional (patient).  This female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 04Jan2021 at single dose for COVID-19 immunisation. Relevant medical history and concomitant medications were not reported. On 11Jan2021, the patient started developing symptoms such as loss of smell and, on 12Jan2021, she tested positive for COVID from 2 rapid tests and a PCR test. The outcome of the events was unknown.  The information on Lot/Batch number has been requested.; Sender's Comments: Based on the mechanism of action of BNT162B2 vaccine, it is unlikely the patient would have fully developed immunity for the vaccine to be effective, due to the number of days passed since the vaccine was given (7 days in this case). However, a causal relationship between event "positive COVID-19 test with symptoms" (coded to Drug ineffective / COVID-19) and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be completely excluded.
Information has been received from a licensed practical nurse referring to multiple patients of unknown ages and genders. The patients' medical histories, concurrent conditions and concomitant therapies were not reported. On unknown dates in 2016 (reported as "between 01-MAR-2016 and 14-JUL-2016"), 4 doses of improperly stored ROTATEQ (oral, lot# L008997, expiration date 04-DEC-2016)) were inadvertently administered to the patients. No adverse effect was reported. This is one of several reports received from the same reporter. Additional information has been requested.
joints aching, fatigue, gurgling in chest area, some phelgm, coughing. psoriasis exploded on hands
This spontaneous report as received from a pharmacist via a field representative refers to a 68 year old female patient. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 13-OCT-2015, the patient was vaccinated with a dose of ZOSTAVAX lot # L012477, 1 vial, subcutaneously in unspecified arm (expiration date was not reported). On 14-OCT-2015, the patient experienced swelling "as big as an egg" at the injection site. She sought medical attention, called the pharmacist and subsequently, was scheduled for an appointment with the pharmacist on the day of the report. There were no lab diagnostic studies performed. The outcome of injection site swelling was unknown. The relatedness between the adverse event and ZOSTAVAX was not reported. Additional information has been requested.
Case previously recorded as MA2009-5708. Case received on 20 NOV 2009 via MedCom from a healthcare professional the following information: A 3-year-old male patient was vaccinated i.m. with 0.5ml FLUVIRIN, batch no. 10127801, on 20 NOV 2009. No adverse events were reported. MedCom no:NA09-008676.
6DEC95 mom stated pt began crying uncontrollably w/in an hr p/vax;cried until noc time;unable to console
Rash; Blister; This case was reported by a nurse via call center representative and described the occurrence of rash in a 72-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced rash and blister. On an unknown date, the outcome of the rash and blister were unknown.   It was unknown if the reporter considered the rash and blister to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but it could be 71 or 72 years. The patient experienced blisters and a rash after receiving the 1st dose of Shingrix. The reporter consented to follow up.
pharmacist reported that a pt was inadvertently administered pneumococcal vax Polyvalent IV on 30JAN90; NO further details were provided;
I started feeling very full, queasy, no appetite. I called my general practioner made an appointment. We discussed my symptoms and decided I should see my gastrointestinal specialist, especially since I had lost 15 pounds. Once I went to the gastrointestinal specialist, she ran test to find the issues for the gastroparesis flare. The CT scan came back negative, the endoscopy did show a lot of irritation and GERD. She prescribed Pantoprazole and famotidine; I was unable to take one as it gave me diarrhea.
pt recvd 2 doses of Engerix-B approx 29OCT91 & 29NOV91 & 5DEC91 pt exp systemic swelling of joints, ankles & wrists w/pain;pt recvd 2nd dose of vax 3DEC91 & exp joint swelling, stomach flu, vomiting, fever, diarrhea, general body aches;
Information has been received from a 64 year old female with hypertension, hypothyroidism, cholesterol high and history of shingles who on 01-AUG-2008 was vaccinated with a 0.65mL dose of ZOSTAVAX subcutaneously. Concomitant therapy included Atenolol, Lisinopril, Hydrochlorothiazide and Crestor. On 02-AUG-2008 the patient experienced site reaction of swelling and redness. She also had headache for a few days. The patient sought unspecified medical attention. The patient recovered on 09-AUG-2008 on therapy. Additional information is not expected.
- Achy body - Very sore arm near injection point - Headache - Chills
have periods of "neurologic short circuiting" - entire body freezes up for 3-10 seconds.  Cannot move, blink, breath.  I can see whatever is in my line of vision at the time of freezing up but cannot move my eyes.  Have worn heart montor which shows corresponding ventricular tachycardia at same time as the neurologic episodes. 6/3/21 - 1st episode 4pm (while sitting at my desk working) 6/4/21 - 5pm (watching nephews baseball game) 6/26/21 - 8pm (at wedding reception) 7/2/21 - 10:25am (working - started to black out) 7/8/21 - 11am -4 separate episodes ~ 20 seconds apart (working)  7/9/21 - 1:52pm (working) 7/9/21 - 2:42pm (working) 8/19/21 - 10:52am felt like brain shaking/head exploding (working)
There is something wrong her left knee; Pain went from her arm then went down to her knee/Pain in left knee; Pain went from her arm then went down to her knee/Pain in left knee; This is a spontaneous report from a contactable consumer. A 85-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: EL9265, Expiration date: Unknown) via an unspecified route of administration, in left arm on 30Jan2021 (at the age of 85-year-old) as 1st dose, single for Covid 19 immunisation. The patient medical history and concomitant medications were not reported. It was reported that she was in the hospital for 3-4 days, prior to vaccination, from 21Jan2021 to 23Jan2021, no further details provided. As per report it was reported that "patient got first dose of the Pfizer covid vaccine on Saturday, 30Jan2021 at the (Place name), stated that on Wednesday, Thursday and on that day (03Feb2021), the pain went from her arm then went down to her knee, she has the worst pain in her left knee and she stated that there is something wrong her left knee after getting the first covid vaccine shot. She cannot wear her prosthesis and she has a below the knee prosthesis and right above the kneecap was so painful. She could not stand the pressure, she was rubbing it with everything she has, using icy hot, biofreeze and arthritis Tylenol for the treatment. Stated the pain from the injection was gone. She stated that she was on another medication but did not believe it was relevant. The outcome of events arthropathy, pain extremity and arthralgia was not resolved.   Follow-up attempts completed. No further information expected.
This case was reported by a pharmacist via call center representative and described the occurrence of lung cancer in a 59-year-old male patient who received SHINGRIX for prophylaxis. In June 2018, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced lung cancer (serious criteria GSK medically significant). The patient was treated with chemotherapy, nos (Chemotherapy). On an unknown date, the outcome of the lung cancer was unknown. It was unknown if the reporter considered the lung cancer to be related to SHINGRIX. Additional information was reported as follows: The patient received 1st dose of SHINGRIX on the left deltoid. The patient made the pharmacist aware of a lung cancer diagnosis after receiving the 1st dose of SHINGRIX and at time of 2nd dose administration of SHINGRIX. The patient began chemotherapy in November 2018 and completed therapy at the end of January. At the time of reporting, the reporter did not have batch number, expiry date and additional details. The pharmacist did not have more in depth details.
Pt recv vax on 3/4/99; on 3/5/99 pt exp pallor, eyes rolled back, stiff body, locked jaw, tongue in back of throat x 45-60 sec followed by diaphoresis & drowsy, fever (99-100)